Biobanking Market Research Report 2022-2027

1
Global Biobanking Market Research and Forecast
Report 2022-2027




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Biobanking Market Research
Report According to the latest report by IMARC
Group, titled Biobanking Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2022-2027, the global biobanking market
reached a strong growth in 2021.  Biobanking
refers to the process of storing and analyzing
information regarding human biospecimens, which
are accumulated from healthy volunteers with a
particular condition. The collected information
is further utilized in research and academic
studies to enhance the understanding of health
and numerous diseases. Modern biobanks indulge in
the large-scale analysis of specific disease
biomarkers, which include biological or digital
materials with well-annotated clinical data. They
offer a basis for enhancing personalized medical
approaches where effective biomarker
identification is crucial for diagnosis and
prognosis. Request Free Sample Report
https//www.imarcgroup.com/biobanking-market/reque
stsample
4
Report Description and Highlights
Report Description
Global Biobanking Market Trends The growing
incidences of new infectious and chronic diseases
and the escalating need for diagnostic procedures
that accurately identify pathogens are primarily
driving the biobanking market. Moreover, the
increasing demand for regenerative medicines and
personalized treatment options is further
propelling the market growth. Besides this,
several technological advancements in genomics,
metagenomics, proteomics, disease biology,
bioenergy, environmental remediation, and allied
fields are acting as significant growth-inducing
factors. Furthermore, the expanding investments
in virtual biobank network models by the health
agencies across numerous countries are also
augmenting the global market. In addition to
this, various key market players are providing a
diverse portfolio of biobanking products and
services that allow the seamless sharing of
insights and critical information between
research establishments. This, in turn, is
anticipated to fuel the biobanking market over
the forecasted period. Looking forward, the
market value is projected to reach a strong
growth during the forecast period (2022-2027).

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Specimen Type
• Blood Products
• Solid Tissue
• Cell Lines
• Nucleic Acid
• Others
• Breakup by Biobank Type
• Population-based Biobanks
• Disease-oriented Biobanks
• Breakup by Application
• Therapeutics
• Research
• Breakup by End User
• Academic Institutions

6
Report Description and Highlights
Report Description

• Breakup by Region
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia

7
Report Description and Highlights
Report Description

• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• Note We are updating our reports, If you want
  latest primary and secondary data (2022-2027)
  with Cost Module, Business Strategy, Distribution
  Channel, etc. Click request free sample report.

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Brooks Automation Inc.
• Bay Biosciences LLC
• Boca Biolistics
• Ctibiotech
• Cureline Inc.
• Firalis
• Greiner Bio-One International GmbH
• Hamilton Company
• Merck KGaA
• ProteoGenex Inc.
• Thermo Fisher Scientific Inc.
• VWR Corporation (Avantor Inc.)
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/biobanking-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us